|
1
|
Rassenti LZ, Jain S, Keating MJ, et al:
Relative value of ZAP-70, CD38, and immunoglobulin mutation status
in predicting aggressive disease in chronic lymphocytic leukemia.
Blood. 112:1923–1930. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Scrivener S, Goddard RV, Kaminski ER and
Prentice AG: Abnormal T-cell function in B-cell chronic lymphocytic
leukaemia. Leuk Lymphoma. 44:383–389. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gabrilovich DI and Nagaraj S:
Myeloid-derived suppressor cells as regulators of the immune
system. Nat Rev Immunol. 9:162–174. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hoechst B, Ormandy LA, Ballmaier M, et al:
A new population of myeloid-derived suppressor cells in
hepatocellular carcinoma patients induces
CD4+CD25+Foxp3+ T cells.
Gastroenterology. 135:234–243. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Filipazzi P, Valenti R, Huber V, et al:
Identification of a new subset of myeloid suppressor cells in
peripheral blood of melanoma patients with modulation by a
granulocyte-macrophage colony-stimulation factor-based antitumor
vaccine. J Clin Oncol. 25:2546–2553. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lin Y, Gustafson MP, Bulur PA, Gastineau
DA, Witzig TE and Dietz AB: Immunosuppressive
CD14+HLA-DR(low)/− monocytes in B-cell
non-Hodgkin lymphoma. Blood. 117:872–881. 2011. View Article : Google Scholar :
|
|
7
|
Jaffe ES: The 2008 WHO classification of
lymphomas: implications for clinical practice and translational
research. Hematology Am Soc Hematol Educ Program. 523–531. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hallek M, Cheson BD, Catovsky D, et al:
International Workshop on Chronic Lymphocytic Leukemia: Guidelines
for the diagnosis and treatment of chronic lymphocytic leukemia: a
report from the International Workshop on Chronic Lymphocytic
Leukemia updating the National Cancer Institute - Working Group
1996 guidelines. Blood. 111:5446–5456. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gharagozlou S, Kardar GA, Rabbani H and
Shokri F: Molecular analysis of the heavy chain variable region
genes of human hybridoma clones specific for coagulation factor
VIII. Thromb Haemost. 94:1131–1137. 2005.
|
|
10
|
Ghia P and Caligaris-Cappio F: Monoclonal
B-cell lymphocytosis: right track or red herring? Blood.
119:4358–4362. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Orchard JA, Ibbotson RE, Davis Z, et al:
ZAP-70 expression and prognosis in chronic lymphocytic leukaemia.
Lancet. 363:105–111. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Damle RN, Wasil T, Fais F, et al: Ig V
gene mutation status and CD38 expression as novel prognostic
indicators in chronic lymphocytic leukemia. Blood. 94:1840–1847.
1999.PubMed/NCBI
|
|
13
|
Hallek M: Signaling the end of chronic
lymphocytic leukemia: new frontline treatment strategies. Blood.
122:3723–3734. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Marx J: Cancer immunology. Cancer’s
bulwark against immune attack: MDS cells. Science. 319:154–156.
2008. View Article : Google Scholar : PubMed/NCBI
|
